| 2025-12-16 |
复牌提示：
2025-12-15 11:01:27 停牌，复牌日期 2025-12-15 11:06:27
|
| 2025-12-05 |
详情>>
内部人交易：
RICCI PAUL股份减少69431.00股
|
| 2025-11-13 |
详情>>
股本变动：
变动后总股本7785.91万股
|
| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-3.75美元,归母净利润-2.01亿美元,同比去年增长12.32%
|
| 2025-11-13 |
财报披露：
美东时间 2025-11-13 盘后发布财报
|
| 2025-08-13 |
详情>>
业绩披露：
2025年中报每股收益-2.44美元,归母净利润-1.11亿美元,同比去年增长56.62%
|
| 2025-06-06 |
股东大会：
将于2025-07-03召开股东大会
会议内容 ▼▲
- 1.Election of three Class II directors.
2.Ratification of the appointment of KPMG LLP as the independent registered public accounting firm of Luminar Technologies, Inc. (the “Company”) for the fiscal year ending December 31, 2025.
3.Approval on an advisory (non-binding) basis of the compensation of our named executive officers.
4.Approval for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of our Class A common stock pursuant to that certain Securities Purchase Agreement, dated May 19, 2025 (the “Purchase Agreement”) entered into in connection with a Series A Convertible Preferred Stock financing with certain institutional accredited investors, without giving effect to the 19.99% cap under Nasdaq Listing Rule 5635(d).
5.Approval of an amendment to the Luminar Technologies, Inc. Amended and Restated 2020 Equity Incentive Plan to increase the authorized share reserve.
6.Transact any other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2025-05-20 |
详情>>
业绩披露：
2025年一季报每股收益-1.92美元,归母净利润-8069.1万美元,同比去年增长35.81%
|
| 2025-03-28 |
详情>>
业绩披露：
2024年年报每股收益-8.7美元,归母净利润-2.73亿美元,同比去年增长52.19%
|
| 2025-03-28 |
详情>>
业绩披露：
2022年年报每股收益-18.79美元,归母净利润-4.46亿美元,同比去年增长-87.38%
|
| 2024-11-21 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2024-11-18 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.51美元,归母净利润-2.29亿美元,同比去年增长45.87%
|
| 2024-09-16 |
股东大会：
将于2024-10-30召开股东大会
会议内容 ▼▲
- 1.Approve an amendment to our Second Amended and Restated Certificate of Incorporation, as amended (the “Charter”) to, at the discretion of our board of directors, effect a reverse stock split with respect to our issued and outstanding Class A Common Stock and Class B Common Stock (collectively, the “Common Stock”), including any Common Stock held by the Company as treasury shares, at any time prior to December 31, 2024, at a ratio of 1-for-5 to 1-for-20 (the “Range”), with the ratio within such Range to be determined at the discretion of our board of directors without further approval or authorization of our stockholders (the “Reverse Stock Split Proposal”).
2.Authorize an adjournment or adjournments of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal.
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.58美元,归母净利润-2.56亿美元,同比去年增长11.16%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益-0.77美元,归母净利润-2.89亿美元,同比去年增长-57.18%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益-0.3美元,归母净利润-1.26亿美元,同比去年增长14.35%
|
| 2024-04-25 |
股东大会：
将于2024-06-05召开股东大会
会议内容 ▼▲
- 1.Election of three Class I directors.
2.Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of Luminar Technologies, Inc. (the “Company”) for the fiscal year ending December 31, 2024.
3.Approval on an advisory (non-binding) basis of the compensation of our named executive officers.
4.Approval of the amendment and restatement of the Luminar Technologies, Inc. 2020 Equity Incentive Plan to increase the authorized share reserve.
5.Transact any other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益-1.47美元,归母净利润-5.71亿美元,同比去年增长-28.1%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.11美元,归母净利润-4.23亿美元,同比去年增长-40.43%
|
| 2023-04-28 |
股东大会：
将于2023-06-07召开股东大会
会议内容 ▼▲
- 1.Election of two Class III directors.
2.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of Luminar Technologies, Inc. (the “Company”) for the fiscal year ending December 31, 2023.
3.Advisory (non-binding) vote to approve the compensation of our named executive officers.
4.Approval of an amendment to the Second Amended and Restated Certificate of Incorporation of the Company to reflect Delaware law provisions allowing officer exculpation.
5.Transact any other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2022-05-06 |
股东大会：
将于2022-06-07召开股东大会
会议内容 ▼▲
- 1.Election of Class II directors.
2.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of Luminar Technologies, Inc. for the fiscal year ending December 31, 2022.
3.Advisory (non-binding) vote to approve the compensation of our named executive officers.
4.Advisory (non-binding) vote on the frequency of future advisory votes on executive compensation.
5.Approve the amendment and restatement of the Luminar Technologies, Inc. 2020 Equity Incentive Plan to increase the authorized share reserve and add an automatic annual share reserve increase provision.
6.Transact any other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-09召开股东大会
会议内容 ▼▲
- 1.Elect the three Class I directors listed in the accompanying proxy statement, each to serve a three-year term expiring at the 2024 annual meeting of stockholders or until such director’s successor is duly elected and qualified or until such director’s earlier death, resignation, disqualification or removal.
2.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of Luminar Technologies, Inc. for the fiscal year ending December 31, 2021.
3.Transact any other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2020-10-30 |
股东大会：
将于2020-12-01召开股东大会
会议内容 ▼▲
- 1.Transaction Proposal-To consider and vote upon a proposal to approve the Agreement and Plan of Merger, dated as of August 24, 2020 (as it may be amended from time to time, the “Merger Agreement”), by and among the Company, Dawn Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“First Merger Sub”), Dawn Merger Sub II, LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of the Company (“Second Merger Sub”), and Luminar Technologies, Inc., a Delaware corporation (“Luminar”), a copy of which is attached to this proxy statement/consent solicitation statement/prospectus as Annex A, and approve the transactions contemplated thereby, including, among other things, the merger of First Merger Sub with and into Luminar, with Luminar continuing as the Surviving Corporation (the “First Merger”), and immediately following the First Merger and as part of the same overall transaction as the First Merger, the merger of Luminar with and into Second Merger Sub, with Second Merger Sub continuing as the Surviving Entity (the “Second Merger” and, together with the First Merger and the other transactions contemplated by the Merger Agreement, the “Business Combination”) (Proposal No. 1);
2.Issuance Proposal-To consider and vote upon a proposal to approve, for purposes of complying with applicable Nasdaq listing rules, the issuance of more than 20% of the Company’s issued and outstanding shares of Class A common stock, par value $0.0001 per share, of the Company (the “Class A Stock”) and Class F common stock, par value $0.0001 per share, of the Company (the “Class F Stock” and, together with the Class A Stock, and following the Business Combination, the Class B common stock, par value $0.0001 per share, of the Post-Combination Company, the “Common Stock”) in connection with the Business Combination (as defined below) (Proposal No. 2);
3.Amendment Proposal-To consider and act upon a proposal to adopt the proposed Second Amended and Restated Certificate of Incorporation of the Company in the form attached hereto as Annex B (Proposal No. 3);
4.Governance Proposal-To consider and act upon, on a non-binding advisory basis, a separate proposal with respect to certain governance provisions in the Second Amended and Restated Certificate of Incorporation in accordance with the United States Securities and Exchange Commission (“SEC”) requirements (Proposal No. 4);
5.Management Longer Term Equity Incentive Plan Proposal-To consider and vote upon a proposal to approve the Management Longer Term Equity Incentive Plan (the “Management Longer Term Equity Incentive Plan”), including the authorization of the initial share reserve under the Management Longer Term Equity Incentive Plan (Proposal No. 5);
6.Omnibus Incentive Plan Proposal-To consider and vote upon a proposal to approve the 2020 Equity Incentive Plan (the “Omnibus Incentive Plan”), including the authorization of the initial share reserve under the Omnibus Incentive Plan (Proposal No. 6);
7.Employee Stock Purchase Plan Proposal-To consider and vote upon a proposal to approve the 2020 Employee Stock Purchase Plan (the “Employee Stock Purchase Plan”), including the authorization of the initial share reserve under the Employee Stock Purchase Plan (Proposal No. 7);
8.Director Election Proposal-To consider and vote upon a proposal to elect five directors to serve staggered terms on the Company’s Board until the first, second and third annual meetings of stockholders following the date of the filing of the Second Amended and Restated Certificate of Incorporation, as applicable, and until their respective successors are duly elected and qualified (Proposal No. 8);
9.Adjournment Proposal-To consider and vote upon a proposal to allow the chairman of the Special Meeting to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Transaction Proposal, the Issuance Proposal, the Amendment Proposal, the Management Longer Term Equity Incentive Plan Proposal or the Omnibus Incentive Plan Proposal but no other proposal if the Transaction Proposal, the Issuance Proposal, the Amendment Proposal, the Management Longer Term Equity Incentive Plan Proposal and the Omnibus Incentive Plan Proposal are approved (Proposal No. 9).
|